# Prasugrel

## Efient 3.75mg

##### 臨採

| 藥品代碼   | OEFI3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Percutaneous coronary intervention (PCI) for Acute coronary syndrome (ACS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | Loading dose: 20 mg; Maintenance dose: 3.75 mg QD. Not recommended taking Efient on empty stomach except loading dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 禁忌       | Hypersensitivity (eg， anaphylaxis) to prasugrel or any component of the formulation; active pathological bleeding (eg， peptic ulcer， intracranial hemorrhage); prior transient ischemic attack or stroke.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用     | 1% to 10%: Cardiovascular: Hypertension (8%)， hypotension (4%)， atrial fibrillation (3%)， bradycardia (3%)， peripheral edema (3%) Central nervous system: Headache (6%)， dizziness (4%)， fatigue (4%)， noncardiac chest pain (3%) Dermatologic: Skin rash (3%) Endocrine & metabolic: Hypercholesterolemia (?7%)， hyperlipidemia (?7%) Gastrointestinal: Nausea (5%)， diarrhea (2%)， gastrointestinal hemorrhage (2%) Hematologic & oncologic: Leukopenia (3%)， anemia (2%)， major hemorrhage (2%)， minor hemorrhage (2%)， major hemmorhage (life-threatening: 1%) Neuromuscular & skeletal: Back pain (5%)， limb pain (3%) Respiratory: Epistaxis (6%)， dyspnea (5%)， cough (4%) Miscellaneous: Fever (3%) <1%， postmarketing， and/or case reports: Abnormal hepatic function tests， anaphylaxis， angioedema， hematoma， hemoptysis， hemorrhage (requiring inotropes or transfusion)， hypersensitivity reaction， intracranial hemorrhage (symptomatic)， re-operation due to bleeding， thrombocytopenia， thrombotic thrombocytopenic purpura |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

